BHV-8100

N/A

Report date: 2026/01/27 10:48:46
NME

Base Information

Drug NameBHV-8100
Drug Alias NameBHV-8100BHV8100
ClassificationSmall molecules
Mechanisms of ActionPyruvate kinase isozymes M1/M2 activators
TargetsPyruvate kinase isozymes M1/M2
Therapy Area/IndicationsNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiohaven Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiohaven Ltd
Inactive CompaniesN/A
Active IndicationsNeurodegenerative Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A